Growth Metrics

Baxter International (BAX) Cost of Revenue (2016 - 2024)

Baxter International (BAX) has disclosed Cost of Revenue for 16 consecutive years, with $1.8 billion as the latest value for Q4 2024.

  • Quarterly Cost of Revenue rose 247.65% to $1.8 billion in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $7.3 billion through Dec 2024, up 18.0% year-over-year, with the annual reading at $7.9 billion for FY2025, 18.24% up from the prior year.
  • Cost of Revenue for Q4 2024 was $1.8 billion at Baxter International, up from $1.7 billion in the prior quarter.
  • The five-year high for Cost of Revenue was $2.6 billion in Q2 2023, with the low at -$1.2 billion in Q4 2023.
  • Average Cost of Revenue over 5 years is $1.7 billion, with a median of $1.9 billion recorded in 2021.
  • The sharpest move saw Cost of Revenue plummeted 131.0% in 2022, then skyrocketed 247.65% in 2024.
  • Over 5 years, Cost of Revenue stood at $2.0 billion in 2020, then dropped by 6.78% to $1.9 billion in 2021, then tumbled by 131.0% to -$575.0 million in 2022, then crashed by 111.3% to -$1.2 billion in 2023, then surged by 247.65% to $1.8 billion in 2024.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $1.8 billion, $1.7 billion, and $1.7 billion for Q4 2024, Q3 2024, and Q2 2024 respectively.